United States · Funded startup

Who invested in Saros Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$2.0Mraised across 1 round since 2023, from 1 source

Latest round
Grant, $2.0MSept 2023
Investors
1
See who backed them

The rounds

  1. Sept 2023
    Grant$2.0M

    Source recorded

Founders and team

From Saros Therapeutics's own website: 1 on the team.

  • Steven KuemmerleBioTech Consultant and Board Member

Everyone who backed them

National Cancer Institute (NCI)Investment firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Saros Therapeutics

Who invested in Saros Therapeutics?

Saros Therapeutics's investors include National Cancer Institute (NCI).

How much has Saros Therapeutics raised?

Saros Therapeutics has raised $2.0M across 1 round since 2023.

When did Saros Therapeutics last raise?

Saros Therapeutics's most recent round was a Grant of $2.0M in Sept 2023.

What was Saros Therapeutics's biggest round?

Its most recent round, $2.0M in Sept 2023, is also its largest on record.

Who backed Saros Therapeutics first?

Saros Therapeutics's first round on record, in Sept 2023, was backed by National Cancer Institute (NCI).

What stage is Saros Therapeutics at?

Saros Therapeutics's latest named round is a Grant, in Sept 2023.

Where is Saros Therapeutics based?

Saros Therapeutics is based in the United States.

Companies like Saros Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.